Meeting
2014 ASCO Annual Meeting
Mitomycin C, doxorubicin, and cisplatin as a safe and effective preoperative chemoradiation cocktail for soft tissue sarcomas.
Authors
Meera Sridharan
Mayo Clinic, Rochester, MN
Meera Sridharan , Ivy Ann Petersen , Peter S. Rose , Karen Fritchie , Scott H. Okuno , Steven Ian Robinson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 10593)
DOI
10.1200/jco.2014.32.15_suppl.10593
Abstract #
10593
Poster Bd #
300
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
The impact of multimodality therapy in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program Experience.
First Author: Samer Salah
Poster
2023 ASCO Annual Meeting
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate as neoadjuvant therapy for osteosarcoma: A single-arm, exploratory phase II trial.
First Author: Qinglian Tang
Poster
2021 ASCO Annual Meeting
The impact of multimodality therapies in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program (TSP) experience.
First Author: Olga Vornicova
Poster
2012 ASCO Annual Meeting
Intensive alternating 6-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma in children and adolescents: Impact on survival.
First Author: Gerges Attia Demian